News

October 20, 2020

Startup company founded by Washington University scientists acquired by Eli Lilly

Drugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.

Medical Campus & Community

February 10, 2020

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates

Top-line data reported from international trial.

News Release